HighPoint Advisor Group’s Idexx Laboratories IDXX Stock Holding History

HighPoint Advisor Group’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$290K	Buy	550 +1	+0.2%	+$561	0.01%	587
2026 Q1	$308K	Sell	549 -2,114	-79%	-$1.36M	0.01%	526
2025 Q4	$1.8M	Buy	2,663 +1,763	+196%	+$1.2M	0.04%	333
2025 Q3	$575K	Sell	900 -42	-4%	-$25.5K	0.03%	358
2025 Q2	$505K	Buy	942 +27	+3%	+$12.9K	0.03%	371
2025 Q1	$400K	Buy	915 +360	+65%	+$156K	0.02%	414
2024 Q4	$257K	Sell	555 -178	-24%	-$78.1K	0.01%	565
2024 Q3	$306K	Sell	733 -146	-17%	-$70.9K	0.02%	485
2024 Q2	$417K	Buy	879 +37	+4%	+$18.6K	0.02%	391
2024 Q1	$424K	Buy	842 +15	+2%	+$8.2K	0.03%	389
2023 Q4	$438K	Buy	+827	New	+$388K	0.03%	384
2021 Q3	$1.08M	Buy	+1,742	New	+$1.17M	0.11%	153

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

HighPoint Advisor Group's IDXX Position: Q2 2026 in Review

HighPoint Advisor Group increased its Idexx Laboratories (IDXX) stake by 0.18% in Q2 2026, buying an estimated $561 and bringing the position to 550 shares worth $290K. The position accounts for 0.01% of the portfolio, ranked #587.

HighPoint Advisor Group first reported a position in IDXX in Q3 2021 and has held it in 12 quarters since. The position peaked at $1.8M in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

HighPoint Advisor Group held 550 shares of Idexx Laboratories worth $290K as of Q2 2026.
HighPoint Advisor Group bought 1 Idexx Laboratories share in Q2 2026, an estimated $561.
Idexx Laboratories made up 0.01% of HighPoint Advisor Group's portfolio in Q2 2026, its #587 holding.
HighPoint Advisor Group first reported a position in Idexx Laboratories in Q3 2021 and has held it in 12 quarters since.
HighPoint Advisor Group's Idexx Laboratories position peaked at $1.8M in Q4 2025.
1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on HighPoint Advisor Group's 13F filing for Q2 2026, filed 5 Aug 2026.